Arkema Boosts Specialties with ArrMaz Buy

02:54 EDT 17 May 2019 | CHEManager

Arkema has agreed to buy ArrMaz, a US-based producer of specialty surfactants for crop nutrition, mining and infrastructure, from private equity group Golden Capital for $570 million. The French chemical company said the “milestone” acquisition is another step toward its target of achieving more than 80% of sales in specialties by 2023.

Original Article: Arkema Boosts Specialties with ArrMaz Buy


More From BioPortfolio on "Arkema Boosts Specialties with ArrMaz Buy"

Quick Search


Relevant Topics

Public Health
Alternative Medicine Cleft Palate Complementary & Alternative Medicine Congenital Diseases Dentistry Ear Nose & Throat Food Safety Geriatrics Healthcare Hearing Medical Devices MRSA Muscular Dyst...

Mergers & Acquisitions
Commercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...